NCT07311850: Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
- State
- Under way
- Phase
- Phase 3
- People
- 3,578 taking part
- Started
- 19 Dec 2025
- Primary completion
- 21 Sep 2027
- Arms
- MET097 Dose 1, MET097 Dose 2, MET097 Dose 3
- Results
- None posted
- 19 Dec 2025: Trial started
- 31 Dec 2025: Trial registered